| Metric | Grade | Score | Evidence | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 52 | Negative earnings, weak revenue growth, low valuation appeal offset by modest beta | 6-12M |
| SA Quality/Value Composite | C | 48 | EPS negative (-$0.19), PE 20.1x despite losses; revenue declining YoY (-3.31%) | 6-12M |
| Zacks Earnings Momentum | D | 32 | No forward earnings guidance; YoY EPS growth not disclosed; earnings date unavailable | 1-3M |
| Institutional & Smart Money Flow | B- | 62 | Market cap $436.6M; 52-week return +20.9%; low avg volume (0.22M shares) suggests limited retail attention | 6-12M |
| Growth Sustainability & Moat | D+ | 38 | Revenue declining; no eps_growth_yoy or forward_pe available; high uncertainty on durability | 6-12M |
| Valuation & Safety (Pre-Penalty) | C | 50 | PE 20.1x on negative earnings is nominally high; 52-week range $3.12–$5.27 shows volatility | 6-12M |
| Penalty Overlay | –4 | –4 | Negative earnings, weak profitability flags, no dividend; structural profitability risk | 6-12M |
| CONFIDENCE SCORE | C+ | 56 | Data gaps on earnings date, forward guidance, and eps_growth_yoy limit precision; quote & metrics current | 1-3M |
| Volatility & Drawdown Risk | C | 49 | Beta 0.43 (low systematic risk); intra-day move −2.4%; 52-week drawdown from $5.27 to $4.41 (−16%) | 1-3M |
| Crowding Risk Flag | ✓ Low | 78 | Avg volume 0.22M; micro-cap; limited retail/institutional radar; idiosyncratic risk dominates | 6-12M |
Acacia Research Corp (ACTG) operates in Financial Services, a broad sector that encompasses diverse business models. At $436.6M market capitalization and trading at $4.41, ACTG is a micro-cap with limited institutional depth (avg volume 0.22M shares daily). The company's negative earnings (−$0.19 EPS), declining revenue (−3.3% YoY), and lack of profitability flags place it in the sub-par cohort within financial services. The PE multiple of 20.1x on negative earnings is notional and masks fundamental weakness. Comparable micro-cap financial services players often trade at depressed multiples when unprofitable; ACTG's 52-week return of +20.9% suggests some speculative recovery, yet the absence of forward guidance and earnings momentum metrics limits competitive positioning assessment. Low beta (0.43) indicates defensive characteristics, but profitability recovery is the critical missing link for re-rating.
1–3 Month Outlook: Near-term catalysts are opaque due to missing earnings dates and forward guidance. The −2.4% intra-day move reflects modest volatility around a narrow $4.41 price. Low institutional volume and low beta suggest sideways to slightly downward drift absent positive earnings surprise or strategic news. Risk of further downside toward the 52-week low ($3.12) if revenue decline accelerates or profitability deteriorates further.
6–12 Month Outlook: Medium-term trajectory hinges on return to profitability and stabilization of revenue. The 52-week rally (+20.9%) may represent recovery momentum from oversold levels, but sustainability requires demonstrated earnings turnaround. Lack of forward PE, target price consensus, and detailed guidance leave significant uncertainty. If the company executes cost controls and halts revenue erosion, a 15–25% re-rating is plausible; conversely, continued losses could trigger 20–30% downside. Crowding risk is minimal (positive), reducing forced-sale pressure.
ACTG Stock Analysis & Forecast
Is ACTG a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
ACTG Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, ACTG shows balanced risk-reward characteristics.
Should You Buy ACTG Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in ACTG.